Viking Therapeutics Takeover Target in Biotech Investing?
Investors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
Identify the best retirement plan tailored to your needs. Make informed decisions for a secure financial future.
20,182 articlesInvestors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
The AI boom isn’t over. If you felt you missed the first wave, these three resilient stocks deliver real AI leverage,...
In a speculative timeline, Kevin Warsh is named Federal Reserve Chair, prompting a rethink of policy amid AI-driven g...
Standard Chartered’s chief executive apologized after remarks that some workers are 'lower value' amid a push to auto...
A big investment firm has exited its complete stake in a biotech company, disclosed in an SEC filing. The move provid...
A nuclear startup teams with a national lab to speed up reactor design using AI. This piece breaks down what it could...
Analysts see a path for Intel to reach higher stock levels by 2028 if its foundry expansion and AI data-center moment...
Vanguard’s FTSE Developed Markets ETF has posted stronger gains than the S&P 500 in 2026, drawing renewed investor in...
A mobility startup defies the VC playbook, raising $15 million from private investors. The story highlights disciplin...
Strategy shifted roughly 411 BTC to Coinbase Prime, prompting a fresh look at its cash strategy. The move has revived...
As Autohome reports Q1 2026 earnings, investors get a clear read on user momentum, ad revenue, and margin discipline....
When a top executive sells shares after exercising options, markets take note. This deep dive breaks down Kalvista's ...